Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks

  • 유대현
제목
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
저자
유대현
발행일
2016-11-14
학회명
ACR 2016
개최지
Washington DC, USA